title: [Antiplatelet agents: which one, when and for whom?].
authors.affiliation: Service de médecine interne générale, hôpitaux universitaires de Genève, rue Gabrielle-Perret-Gentil 4, 1211 Genève 14, Suisse. jean-luc.reny@hcuge.ch
authors.forename: J-L
authors.initials: JL
authors.lastname: Reny
authors.forename: A
authors.initials: A
authors.lastname: Zufferey
authors.forename: P
authors.initials: P
authors.lastname: Berdagué
authors.forename: P
authors.initials: P
authors.lastname: Fontana
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D050197:Atherosclerosis / Q000517:prevention & control*; D004359:Drug Therapy, Combination; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D058921:Purinergic P2Y Receptor Antagonists / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D010975:Platelet Aggregation Inhibitors; D058921:Purinergic P2Y Receptor Antagonists
vernacular_title: Antiagrégants plaquettaires : lequel, quand et pour qui ?